BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 192896)

  • 1. A solid-phase radioimmunoassay for Epstein-Barr virus-associated membrane antigen prepared from B95-8 cell culture supernatants.
    Dölken G; Klein G
    J Natl Cancer Inst; 1977 May; 58(5):1239-45. PubMed ID: 192896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of an Epstein-Barr virus-associated membrane antigen component.
    North JR; Morgan AJ; Thompson JL; Epstein MA
    J Virol Methods; 1982 Sep; 5(1):55-65. PubMed ID: 6292251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells.
    Qualtiere LF; Pearson GR
    Int J Cancer; 1979 Jun; 23(6):808-17. PubMed ID: 89099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papain solubilization of the Epstein-Barr virus-induced membrane antigen.
    Pearson GR; Qualtiere LF
    J Virol; 1978 Oct; 28(1):344-51. PubMed ID: 81320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody.
    Szigeti R; Sulitzeanu D; Henle G; Henle W; Klein G
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4178-82. PubMed ID: 6330746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an Epstein-Barr virus nuclear antigen by fluoroimmunoelectrophoresis and radioimmunoelectrophoresis.
    Strnad BC; Schuster TC; Hopkins RF; Neubauer RH; Rabin H
    J Virol; 1981 Jun; 38(3):996-1004. PubMed ID: 7017165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunoassay for Epstein--Barr virus (EBV)-associated nuclear antigen (EBNA). Binding of iodinated antibodies to antigen immobilized in polyacrylamide gel.
    Dölken G; Klein G
    Eur J Cancer (1965); 1977 Nov; 13(11):1277-86. PubMed ID: 73461
    [No Abstract]   [Full Text] [Related]  

  • 8. Demonstration of a surface antigen on Epstein-Barr virus genome-carrying lymphoid cells: distinction from the virus-determined membrane antigen.
    Sakamoto K; Hinuma Y
    J Immunol; 1978 May; 120(5):1702-8. PubMed ID: 207776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cross-reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cells.
    Thorley-Lawson DA
    Cell; 1979 Jan; 16(1):33-42. PubMed ID: 217544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of Epstein-Barr virus specific proteins expressed by three Epstein-Barr virus isolates using specific monoclonal antibodies.
    Tsai CH; Glaser R
    Intervirology; 1991; 32(6):376-82. PubMed ID: 1657827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between Epstein-Barr virus membrane antigen and three large cell surface glycoproteins.
    Strnad BC; Neubauer RH; Rabin H; Mazur RA
    J Virol; 1979 Dec; 32(3):885-94. PubMed ID: 92577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic differences between the membrane antigen polypeptides determined by different EB virus isolates.
    Franklin SM; North JR; Morgan AJ; Epstein MA
    J Gen Virol; 1981 Apr; 53(Pt 2):371-6. PubMed ID: 6167667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-phase radioimmunoassays for Epstein-Barr virus associated antigens.
    Dölken G; Gier A; Finke J; Weitzmann U
    Ric Clin Lab; 1982; 12(1):307-12. PubMed ID: 6283618
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel surface antigen on lymphoid cells transformed by Epstein-Barr virus.
    Hinuma Y; Sakamoto K
    IARC Sci Publ (1971); 1978; (24 Pt 1):249-51. PubMed ID: 87368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic peptides to identify antigenic determinants on Epstein-Barr virus gp350/220.
    Bertoni G; Kostyal DA; Reisert PS; Humphreys RE; Sairenji T
    Intervirology; 1990; 31(5):290-4. PubMed ID: 1703134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and quantification of recombinant Epstein-Barr viral glycoproteins gp350/220 from Chinese hamster ovary cells.
    Hessing M; van Schijndel HB; van Grunsven WM; Wolf H; Middeldorp JM
    J Chromatogr; 1992 May; 599(1-2):267-72. PubMed ID: 1320046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
    Fresen KO; zur Hausen H
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appearance of early and late components of Epstein-Barr virus-associated membrane antigen in Daudi cells superinfected with P3HR-1 virus.
    Sairenji T; Hinuma Y; Sekizawa T; Yoshida M
    J Gen Virol; 1978 Jan; 38(1):111-20. PubMed ID: 202665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens.
    Pearson GR; Orr TW
    J Natl Cancer Inst; 1976 Mar; 56(3):485-8. PubMed ID: 176393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypeptides of the Epstein-Barr virus membrane antigen complex.
    Thorley-Lawson DA; Edson CM
    J Virol; 1979 Nov; 32(2):458-67. PubMed ID: 228070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.